80 FR 63626 - Accentia Biopharmaceuticals, Inc. and Biostem U.S. Corp., Order of Suspension of Trading

SECURITIES AND EXCHANGE COMMISSION

Federal Register Volume 80, Issue 202 (October 20, 2015)

[Federal Register Volume 80, Number 202 (Tuesday, October 20, 2015)]
[Notices]
[Pages 63626-63627]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-26722]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Accentia Biopharmaceuticals, Inc. and Biostem U.S. Corp., Order 
of Suspension of Trading

October 16, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Accentia Biopharmaceuticals, Inc. (CIK No. 1310094), a dissolved 
Florida corporation with its principal place of business listed as 
Tampa, Florida, with stock quoted on OTC Link (previously, ``Pink 
Sheets'') operated by OTC Markets Group, Inc. (``OTC Link'') under the 
ticker symbol ABPI, because it has not filed any periodic reports since 
the period ended December 31, 2012. On October 27, 2014, Accentia 
Biopharmaceuticals received a delinquency letter sent by the Division 
of Corporation Finance requesting compliance with their periodic filing 
obligations.

[[Page 63627]]

    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Biostem U.S. Corp. (CIK No. 1455380), a revoked Nevada corporation with 
its principal place of business listed as Clearwater, Florida, with 
stock quoted on OTC Link under the ticker symbol HAIR, because it has 
not filed any periodic reports since the period ended November 30, 
2012. On November 7, 2014, the Division of Corporation Finance sent 
Biostem U.S. a delinquency letter requesting compliance with their 
periodic filing obligations, but the letter was returned because of 
Biostem U.S.'s failure to maintain a valid address on file with the 
Commission, as required by Commission rules (Rule 301 of Regulation S-
T, 17 CFR 232.301 and Section 5.4 of EDGAR Filer Manual).
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed companies is suspended for the period from 9:30 a.m. EDT 
on October 16, 2015, through 11:59 p.m. EDT on October 29, 2015.

    By the Commission.
Brent J. Fields
Secretary.
[FR Doc. 2015-26722 Filed 10-16-15; 11:15 am]
 BILLING CODE 8011-01-P